| An evaluation of the variation and underuse of clozapine in the United Kingdom E Whiskey, A Barnard, E Oloyede, O Dzahini, DM Taylor, SS Shergill Acta Psychiatrica Scandinavica 143 (4), 339-347, 2021 | 50 | 2021 |
| Clozapine haematological monitoring for neutropenia: a global perspective E Oloyede, G Blackman, E Whiskey, C Bachmann, O Dzahini, S Shergill, ... Epidemiology and Psychiatric Sciences 31, e83, 2022 | 47 | 2022 |
| Clozapine discontinuation withdrawal symptoms in schizophrenia G Blackman, E Oloyede Therapeutic Advances in Psychopharmacology 11, 20451253211032053, 2021 | 40 | 2021 |
| Reducing the risk of withdrawal symptoms and relapse following clozapine discontinuation—is it feasible to develop evidence-based guidelines? G Blackman, E Oloyede, M Horowitz, R Harland, D Taylor, J MacCabe, ... Schizophrenia Bulletin 48 (1), 176-189, 2022 | 37 | 2022 |
| There is life after the UK clozapine central non-rechallenge database E Oloyede, C Casetta, O Dzahini, A Segev, F Gaughran, S Shergill, ... Schizophrenia Bulletin 47 (4), 1088-1098, 2021 | 32 | 2021 |
| Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy A Segev, E Iqbal, TA McDonagh, C Casetta, E Oloyede, S Piper, ... The British journal of psychiatry 219 (6), 644-651, 2021 | 29 | 2021 |
| Relaxation of the criteria for entry to the UK clozapine central non-rechallenge database: a modelling study E Oloyede, E Whiskey, C Casetta, O Dzahini, D Dunnett, S Gandhi, ... The Lancet Psychiatry 9 (8), 636-644, 2022 | 23 | 2022 |
| Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review E Oloyede, I Clark, S Mace, E Whiskey, D Taylor Therapeutic Advances in Psychopharmacology 12, 20451253211066642, 2022 | 23 | 2022 |
| Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration A Egerton, K Griffiths, C Casetta, B Deakin, R Drake, OD Howes, ... Neuropsychopharmacology 48 (3), 567-575, 2023 | 21 | 2023 |
| Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals E Oloyede, O Dzahini, N Barnes, A Mijovic, S Gandhi, S Stuart-Smith, ... BMC psychiatry 21, 1-11, 2021 | 17 | 2021 |
| A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis C Casetta, E Oloyede, E Whiskey, DM Taylor, F Gaughran, SS Shergill, ... The British Journal of Psychiatry 217 (3), 506-513, 2020 | 17 | 2020 |
| What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians E Oloyede, G Blackman, B Mantell, E Harris, J Williams, D Taylor, ... Schizophrenia 9 (1), 26, 2023 | 15 | 2023 |
| Patients’ experiences of clozapine for treatment-resistant schizophrenia: a systematic review S Parkes, B Mantell, E Oloyede, G Blackman Schizophrenia Bulletin Open 3 (1), sgac042, 2022 | 13 | 2022 |
| Clozapine and norclozapine plasma levels in patients switched between different liquid formulations E Oloyede, O Dzahini, E Whiskey, D Taylor Therapeutic Drug Monitoring 42 (3), 491-496, 2020 | 12 | 2020 |
| Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study E Oloyede, O Dzahini, Z Abolou, S Gee, E Whiskey, D Malhotra, ... The British Journal of Psychiatry 223 (2), 382-388, 2023 | 11 | 2023 |
| International variation in clozapine hematologic monitoring—a call for action E Oloyede, D Taylor, J MacCabe JAMA psychiatry 80 (6), 535-536, 2023 | 11 | 2023 |
| Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study C Casetta, F Gaughran, E Oloyede, J Onwumere, M Pritchard, SS Shergill, ... BJPsych Open 6 (5), e82, 2020 | 9 | 2020 |
| The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia E Oloyede, D Dunnett, D Taylor, I Clark, JH MacCabe, E Whiskey, ... BMC psychiatry 23 (1), 413, 2023 | 7 | 2023 |
| Incident infection during the first year of treatment–a comparison of clozapine and paliperidone palmitate long-acting injection S Mace, O Dzahini, V Cornelius, H Langerman, E Oloyede, D Taylor Journal of Psychopharmacology 36 (2), 232-237, 2022 | 7 | 2022 |
| Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence E Oloyede, B Mantell, J Williams, S Lai, S Jauhar, D Taylor, JH MacCabe, ... Therapeutic Advances in Psychopharmacology 12, 20451253221141222, 2022 | 6 | 2022 |
